Vivani Medical (STU:U5P) Debt-to-Asset : 0.46 (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vivani Medical Debt-to-Asset?

Vivani Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €1.25 Mil. Vivani Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €16.48 Mil. Vivani Medical's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was €38.65 Mil. Vivani Medical's debt to asset for the quarter that ended in Sep. 2024 was 0.46.

Vivani Medical Debt-to-Asset Historical Data

The historical data trend for Vivani Medical's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivani Medical Debt-to-Asset Chart

Vivani Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.47

0.33

0.02

0.45

Vivani Medical Quarterly Data
	Dec20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial										0.40	0.45	0.38	0.42	0.46

Competitive Comparison of Vivani Medical's Debt-to-Asset

For the Biotechnology subindustry, Vivani Medical's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivani Medical's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivani Medical's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Vivani Medical's Debt-to-Asset falls into.

Vivani Medical Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Vivani Medical's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.268	+	17.71)	/	41.996
	=	0.45

Vivani Medical's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.248	+	16.483)	/	38.649
	=	0.46

Vivani Medical (STU:U5P) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Vivani Medical Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Vivani Medical's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivani Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivani Medical Inc (STU:U5P) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

VANI:USA U5P:Germany

Address

1350 S. Loop Road, Alameda, CA, USA, 94502

Website

https://www.vivani.com

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.

Vivani Medical Headlines

No Headlines